Genoskin to attend the 77th Annual Meeting of the Society for Investigative Dermatology
The 77th Annual Meeting of the Society for Investigative Dermatology (SID2019) is a knowledge hub that connects a diverse group of senior researchers, clinicians and clinical trainees. The SID Meeting appears as a premier forum for the exchange of knowledge in various disciplines, from Dermatology and Immunology to Biomedical Engineering, Cell Biology and Genetics.
From May 8 to May 11, come and meet our Chief Commercial Officer, Eric Merle and Business Development Manager, Michael Pastore at booth #106 in the Southwest Hall, Salon D of the Hilton Chicago Hotel. They’ll be happy to answer all your questions and help your project move forward.
They will also take the opportunity to present three posters:
WoundSkin®, an innovative model to study wound healing
Poster title: “An ex vivo human skin model for healing of infected wound“, (Poster #LB1138, presented by Eric, in partnership with IEMN). Efficient treatment of chronic wounds remains a global challenge. Based on HypoSkin® technology, Genoskin has created an infected wounded model suited to assess the efficacy of wound-healing formulations. HypoSkin® is an ex vivo human skin model containing all skin layers (epidermis, dermis and hypodermis).
Human skin integrity and metabolism preserved for 10 days
Poster title: “NativeSkin® system allows preserving human skin integrity and metabolism during 10 days in culture”, (Poster #LB1136, presented by Eric, in partnership with Promega). NativeSkin® is an ex vivo human skin model, composed of the two upper skin layers. This model can be maintained alive for up to 10 days, with a preserved tissue integrity, a good cell viability and proliferation, and active metabolism. NativeSkin® is then a relevant model to study drug penetration and metabolization after repeated topical application during 10 days.
HypoSkin®, a new model to study skin microbiome
Poster title: “A fully functional ex vivo human skin model to study human skin microbiome“, (Poster #LB1134, presented by Michael, in partnership with Vaiomer). This study aimed to characterize the skin microbiota in the different layers of the ex vivo human skin model HypoSkin®. It also intented to assess the evolution of the skin microbiota overtime during the culture. Overall, HypoSkin® appears as a relevant model to study human skin microbiome and to assess changes following treatment with dermo-cosmetic products.
This year, over 1,600 delegates from nearly 30 countries and over 1,000 abstract submissions are expected at the meeting. SID2019 will serve as a unique platform to forge new cooperation with key opinion leaders, clinical or laboratory scientists, educators and allied health professionals.
Should you like to join Eric and Michael at SID2019, please let us know.
To keep up-to-date with Genoskin’s latest news, follow us on Twitter and LinkedIn. You can also contact us to learn more about our activities and services.
Comments are closed.
